APPENDICURE

Understand the Medical Language of Appendix Cancer Used in Diagnosis, Treatment, and Care

Appendix Cancer Medical Terms

Medical terms can feel overwhelming, especially when you’re facing a rare diagnosis like appendiceal cancer. This section breaks down complex language into clear, patient-friendly definitions to help you better understand your care and communicate with your medical team. Whether you’re reviewing a pathology report or discussing treatment options, these explanations are here to support informed conversations.

• Adenocarcinoid Tumors: Aggressive tumors that are treated similarly to mucinous adenocarcinoma.
• Appendectomy: Removal of the appendix, often sufficient for small neuroendocrine tumors.
• Benign: non-cancerous cells
• Biomarker: Substances in your blood or tissues usually made of cancer cells that help your doctor figure out the best treatments for you, how you’re responding to treatment, or if your cancer has spread or come back.
• Biopsy: A small sample of tissue or cells taken to look at under a microscope.
• Carcinoid Tumor: The most common appendix cancers are Carcinoid tumors, making up about half of those diagnosed. They are usually found at the tip of the appendix. Because there are no symptoms, these tumors are often detected after the appendix has been removed. 
• Cecum:  The cecum attaches the appendix to the large intestine.
• Colostomy:  The re-routing of the large intestine by surgically making an opening (ostomy) in the abdominal wall in order for the body to pass stool. A colostomy is sometimes required after surgery involving the intestines, such as a hemicolectomy, and may be temporary or permanent.
• Completeness of Cytoreduction Score (CC-Score):  A rating of 0
• (best outcome) to 3 (incomplete outcome) of the quality of cytoreduction that was performed.
• Cytoreductive Surgery (CRS): An extensive procedure to remove as many visible tumors and mucin as possible, typically used for more advanced cases.
• FOLFIRI:  A chemotherapy used to treat colon cancers consisting of 5-FU, folinic acid, and irinotecan. It can be given with or without Avastin.
• FOLFOX:  A chemotherapy used to treat colon cancers. It consists of 5-FU, folinic acid, and oxaliplatin. Oxaliplatin can cause neuropathy (nerve damage).
• Goblet Cell Carcinoids: Another name for Adenocarcinoid tumors.
• Hemicolectomy: Removal of the appendix and part of the colon for larger tumors.
• High-Grade Mucinous Carcinoma Peritonei (HGMCP):  Formerly known as Peritoneal Mucinous Adenocarcinoma (PMCA), and refers to the spread of mucin and invasive cancer cells throughout the abdominal cavity, commonly originating from the appendix.
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Often combined with cytoreductive surgery, this procedure circulates a heated chemotherapy solution directly into the abdomen to kill remaining cancer cells.
• Ileostomy:  The re-routing of the small intestine by creating an outlet in the abdominal wall. It is sometimes required after surgery involving the intestines and may be temporary or permanent.
• Malignant: cancerous cells
• Mesothelium:  A membrane that lines internal organs and body cavities, including the peritoneal cavity.
• Mucin:  A jelly-like substance that the body produces to protect the lining of the stomach, intestines, and the appendix.  Cancer cells can produce mucin that cause organs to rupture, such as the appendix, and build up in the abdomenal cavity. This condition is called pseudomyxoma peritonei (PMP).
• Mucinous Adenocarcinoma: This appendix cancer is caused by a range of benign to malignant conditions that cause swelling or sacs from swelling of the appendix wall, typically filled with mucous). These tumors begin in the appendix but are often discovered after they have spread to the peritoneum (lining of the abdominal cavity).
• Mucoceles: Small sacs of mucous in the appendix that can be cancer (malignant) or benign (not cancer). 
• Neuropathy: Cancer treatment or the cancer itself can bring on nerve problems that cause tingling, numbness, weakness, or swelling. It usually starts in your hands and feet.
• Neutropenia: A condition where your body doesn’t have enough infection-fighting white blood cells. It can be a side effect of cancer treatment.
• Omentectomy: The removal of the omentum, a fatty layer that lies on top of the intestines and abdominal organs. It is one of the first sites of tumor spread and is removed during cytoreductive surgery.
• Palliative Care: A support system to improve your quality of life through managing pain and symptoms along with the mental and emotional effects of cancer. It can begin when you’re diagnosed and continue throughout your treatment.
• Paraganglioma: A rare tumor that is often benign (not cancer). 
• Peritoneum: The membrane that lines the abdominal cavity.
• Peritoneal Cancer Index (PCI):  A score from 0-39 used to quantify the amount of tumors in the abdominal cavity.
• Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): A laparoscopic procedure where chemotherapy is pressurized to form a fine mist (aerosol) and then sprayed into the abdominal cavity.
• Pseudomyxoma Peritonei (PMP): Mucinous tumors that have spread throughout the abdominal cavity. It is usually caused by mucinous tumors of the appendix and is categorized as Low-Grade Mucinous Carcinoma Peritonei (LGMCP) or High-Grade Mucinous Carcinoma Peritonei (HGMCP).
• Radiation Therapy: Energy like X-rays and gamma rays kill cancer cells or keep them from growing. A machine will direct radiation from outside your body toward the cancer, or radioactive needles, seeds, or wires will be placed inside you near the cancer.
• Signet-Ring Cell Adenocarcinoma: Signet Ring is a rare and aggressive type of appendix cancer. It often occurs in the stomach or colon, and it may cause appendicitis.
• Systemic Chemotherapy: Administered intravenously to treat cancer that has spread beyond the appendix.
• Total Parenteral Nutrition (TPN):  Intravenous nutrition, including intralipids, provided to patients until they are able to eat food again.
• Tumor Markers: Substances in the blood in response to cancer. They can be used to help diagnose, monitor, and assess the treatment of cancer. Common tumor markers are CA-125, CA 19-9, CEA., and PSA.